Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Novel AI Boosts Geographic Atrophy Clinical Trial Efficiency
A new artificial intelligence (AI) system developed by researchers from UCL and Moorfields Eye Hospital could potentially revolutionize the recruitment process for clinical trials aimed at treating Geographic Atrophy (GA), an advanced form of dry age-related macular degeneration (AMD) that…
VSY Biotechnology: Who Will Shine at the OSA 2024?
VSY Biotechnology GmbH, a leading company with innovative ophthalmic solutions, is now accepting submissions for Ophthalmology Star Awards (OSA) 2024 from eye care professionals worldwide. The awards aim to celebrate and promote novel research and advancements in ophthalmology, with winners…
NVISION Eye Centers Partners with Parkhurst NuVision
NVISION Eye Centers, a prominent provider of eye care services nationwide, announced a strategic collaboration with Parkhurst NuVision of San Antonio, Texas, through its subsidiary NVision Clinical Research, LLC. This partnership aims to advance clinical trials in ophthalmology drug development,…
Notal Vision’s OCT Promises Advances in Wet AMD Management
Notal Vision announced findings from a pioneering clinical trial using home-based optical coherence tomography (OCT) to oversee patients with wet age-related macular degeneration (AMD). Published in Retina, the results highlighted a notable reduction in office visits and treatment frequency, while…
ANI Pharmaceuticals to Acquire Alimera Sciences in $381M Deal
ANI Pharmaceutical has signed a definitive agreement to acquire Alimera at approximately $381 million. The agreement has been approved by both companies’ Boards of Directors and is anticipated to close in the late third quarter of 2024. Alimera Sciences, a…
4DMT Receives FDA Clearance of IND for GA Treatment
4D Molecular Therapeutics (4DMT) announced the FDA clearance of its investigational new drug application (IND) for 4D-175, an R100 vector-based intravitreal genetic medicine intended for treating geographic atrophy (GA) in patients. Phase 1 GAZE Clinical Trial Details The phase 1…
Ikerian Receives EU-MDR Certificate for Four Medical Devices
Ikerian has received European Union Medical Device Regulation (EU-MDR) certificate for its RetinAI Discovery digital data platform and AI-based models. These products have been classified as Class IIa medical devices, affirming their adherence to stringent regulatory standards for healthcare technology.…
VSY Biotechnology’s SVT Granted Patent in China
VSY Biotechnology registered a patent with the People’s Republic of China for the ‘Sinusoidal Vision Technology’ used in AcrivaUD Trinova Pro C Pupil Adaptive®, the world’s first and only sinusoidal trifocal intraocular lens. As a result of evaluations, office actions,…
What Is Staphyloma? | OBN
Staphyloma is a bulging or protrusion of the eye’s inner layers through a thinned area of the outer layers. It is typically caused by a structural weakness in the eye, and it can lead to vision problems if left untreated.…
The 40th Congress of the ESCRS | Milan 16
The 40th Congress of the ESCRS is taking place from 16-20 September 2022, at the Milano Convention Centre in Milan, Italy. The congress, which will host around 1,000 registered participants, will also be streamed via the virtual conferencing platform now…